68 related articles for article (PubMed ID: 15918183)
21. Mismatch repair and cancer.
Jiricny J
Cancer Surv; 1996; 28():47-68. PubMed ID: 8977028
[TBL] [Abstract][Full Text] [Related]
22. Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6, hMSH2) in the pathogenesis of hepatocellular carcinoma.
Zekri AR; Sabry GM; Bahnassy AA; Shalaby KA; Abdel-Wahabh SA; Zakaria S
World J Gastroenterol; 2005 May; 11(20):3020-6. PubMed ID: 15918183
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of mismatch repair genes (hMSH2 and hMLH1) in hepatocellular carcinoma in Egypt.
Helal TE; Khamis NS; El-Sharkawy TM; Nada OH; Radwan NA
APMIS; 2010 Dec; 118(12):934-40. PubMed ID: 21091774
[TBL] [Abstract][Full Text] [Related]
24. Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in salivary gland tumors.
Castrilli G; Fabiano A; La Torre G; Marigo L; Piantelli C; Perfetti G; Ranelletti FO; Piantelli M
J Oral Pathol Med; 2002 Apr; 31(4):234-8. PubMed ID: 12076327
[TBL] [Abstract][Full Text] [Related]
25. DNA mismatch repair genes in renal cell carcinoma.
Deguchi M; Shiina H; Igawa M; Kaneuchi M; Nakajima K; Dahiya R
J Urol; 2003 Jun; 169(6):2365-71. PubMed ID: 12771799
[TBL] [Abstract][Full Text] [Related]
26. Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in ameloblastoma.
Castrilli G; Piantelli M; Artese L; Perfetti G; Rubini C; Fioroni M; Ranelletti FO; Piattelli A
J Oral Pathol Med; 2001 May; 30(5):305-8. PubMed ID: 11334467
[TBL] [Abstract][Full Text] [Related]
27. The pattern of transmission transfusion virus infection in Egyptian patients.
Zekri AR; Sedkey L; el-Din HM; Abdel-Aziz AO; Viazov S
Int J Infect Dis; 2002 Dec; 6(4):329-31. PubMed ID: 12725217
[No Abstract] [Full Text] [Related]
28. Molecular targets for prevention of hepatocellular carcinoma.
Blum HE
Dig Dis; 2002; 20(1):81-90. PubMed ID: 12145424
[TBL] [Abstract][Full Text] [Related]
29. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
[TBL] [Abstract][Full Text] [Related]
30. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
Geisler S; Lønning PE; Aas T; Johnsen H; Fluge O; Haugen DF; Lillehaug JR; Akslen LA; Børresen-Dale AL
Cancer Res; 2001 Mar; 61(6):2505-12. PubMed ID: 11289122
[TBL] [Abstract][Full Text] [Related]
31. [Molecular aspects of hepatocellular carcinoma].
Moradpour D; Blum HE
Zentralbl Chir; 2000; 125(7):592-6. PubMed ID: 10960967
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus genotyping in relation to neu-oncoprotein overexpression and the development of hepatocellular carcinoma.
Zekri AN; Bahnassy AA; Shaarawy SM; Mansour OA; Maduar MA; Khaled HM; El-Ahmadi O
J Med Microbiol; 2000 Jan; 49(1):89-95. PubMed ID: 10628830
[TBL] [Abstract][Full Text] [Related]
33. Allelic instability as a predictor of survival in Egyptian breast cancer patients.
Zekri AR; Bahnassi AA; Bove B; Huang Y; Russo IH; Rogatko A; Shaarawy S; Shawki OA; Hamza MR; Omer S; Khaled HM; Russo J
Int J Oncol; 1999 Oct; 15(4):757-67. PubMed ID: 10493959
[TBL] [Abstract][Full Text] [Related]
34. N-acetyltransferase 2 influences cancer prevalence in hMLH1/hMSH2 mutation carriers.
Heinimann K; Scott RJ; Chappuis P; Weber W; Müller H; Dobbie Z; Hutter P
Cancer Res; 1999 Jul; 59(13):3038-40. PubMed ID: 10397239
[TBL] [Abstract][Full Text] [Related]
35. Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Weber TK; Chin HM; Rodriguez-Bigas M; Keitz B; Gilligan R; O'Malley L; Urf E; Diba N; Pazik J; Petrelli NJ
JAMA; 1999 Jun 23-30; 281(24):2316-20. PubMed ID: 10386556
[TBL] [Abstract][Full Text] [Related]
36. Frequent loss of heterozygosity at the DNA mismatch-repair loci hMLH1 and hMSH3 in sporadic breast cancer.
Benachenhou N; Guiral S; Gorska-Flipot I; Labuda D; Sinnett D
Br J Cancer; 1999 Mar; 79(7-8):1012-7. PubMed ID: 10098729
[TBL] [Abstract][Full Text] [Related]
37. Close correlation between a p53 or hMSH2 gene mutation in the tumor and survival of hepatocellular carcinoma patients.
Yano M; Asahara T; Dohi K; Mizuno T; Iwamoto KS; Seyama T
Int J Oncol; 1999 Mar; 14(3):447-51. PubMed ID: 10024676
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis.
Macdonald GA; Greenson JK; Saito K; Cherian SP; Appelman HD; Boland CR
Hepatology; 1998 Jul; 28(1):90-7. PubMed ID: 9657101
[TBL] [Abstract][Full Text] [Related]
39. Reduced expression of mismatch repair genes in colorectal cancer patients in Egypt.
Soliman AS; Bondy ML; Guan Y; El-Badawi S; Mokhtar N; Bayomi S; Raouf AA; Ismail S; McPherson RS; Abdel-Hakim TF; Beasley RP; Levin B; Wei Q
Int J Oncol; 1998 Jun; 12(6):1315-9. PubMed ID: 9592192
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
